Keytruda is a brand name medication that contains the active ingredient pembrolizumab. It is used to treat various types of cancer, including melanoma, non-small cell lung cancer, and head and neck cancer [1].

The cost of Keytruda can be high, and it may not be covered by insurance for some patients. However, there are financial assistance programs available for eligible patients.

Merck, the manufacturer of Keytruda, offers a program called the Merck Access Program, which provides support to patients who are prescribed Keytruda. This program offers financial assistance to eligible patients who are uninsured or underinsured, as well as those who have insurance but are still experiencing financial difficulties. Patients can apply for this program online or by calling the Merck Access Program hotline [2].

Additionally, the Key+You Support Program provides financial assistance to eligible patients who are prescribed Keytruda for the treatment of hepatocellular carcinoma (HCC). This program can help patients with co-payments, deductibles, and out-of-pocket expenses related to Keytruda treatment. Patients can apply for this program online or by calling the Key+You Support Program hotline [3].

In conclusion, there are financial assistance programs available for eligible patients who are prescribed Keytruda. The Merck Access Program and the Key+You Support Program provide financial assistance to eligible patients who are experiencing financial difficulties related to Keytruda treatment. Patients can apply for these programs online or by calling the respective hotlines.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/KEYTRUDA
[2] https://www.keytruda.com/financial-support/
[3] https://www.merckaccessprogram-keytruda.com/hcc/affordability.html